ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE0009VWHAE6
Stock Name / FundiShares US Equity Enhanced Active UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerUSEE(USD) Euronext Amsterdam

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares US Equity Enhanced Active UCITS ETF USD (Acc) LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-12-03 (Wednesday)14,498USD 14,984,553LLY holding decreased by -182095USD 14,984,5530USD -182,095 USD 1033.56 USD 1046.12
2025-12-02 (Tuesday)14,498USD 15,166,648LLY holding decreased by -170641USD 15,166,6480USD -170,641 USD 1046.12 USD 1057.89
2025-12-01 (Monday)14,498USD 15,337,289LLY holding decreased by -254875USD 15,337,2890USD -254,875 USD 1057.89 USD 1075.47
2025-11-28 (Friday)14,498LLY holding decreased by -1101USD 15,592,164LLY holding decreased by -1634436USD 15,592,164-1,101USD -1,634,436 USD 1075.47 USD 1104.34
2025-11-27 (Thursday)15,599USD 17,226,600USD 17,226,6000USD 0 USD 1104.34 USD 1104.34
2025-11-26 (Wednesday)15,599LLY holding increased by 16USD 17,226,600LLY holding decreased by -69595USD 17,226,60016USD -69,595 USD 1104.34 USD 1109.94
2025-11-25 (Tuesday)15,583LLY holding decreased by -288USD 17,296,195LLY holding increased by 311686USD 17,296,195-288USD 311,686 USD 1109.94 USD 1070.16
2025-11-24 (Monday)15,871LLY holding decreased by -56USD 16,984,509LLY holding increased by 106667USD 16,984,509-56USD 106,667 USD 1070.16 USD 1059.7
2025-11-21 (Friday)15,927USD 16,877,842LLY holding increased by 261362USD 16,877,8420USD 261,362 USD 1059.7 USD 1043.29
2025-11-20 (Thursday)15,927LLY holding increased by 120USD 16,616,480LLY holding increased by 25453USD 16,616,480120USD 25,453 USD 1043.29 USD 1049.6
2025-11-19 (Wednesday)15,807LLY holding decreased by -912USD 16,591,027LLY holding decreased by -630379USD 16,591,027-912USD -630,379 USD 1049.6 USD 1030.05
2025-11-18 (Tuesday)16,719LLY holding decreased by -90USD 17,221,406LLY holding increased by 47651USD 17,221,406-90USD 47,651 USD 1030.05 USD 1021.7
2025-11-17 (Monday)16,809USD 17,173,755LLY holding decreased by -60177USD 17,173,7550USD -60,177 USD 1021.7 USD 1025.28
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE0009VWHAE6

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-28SELL-1,1011,098.8701,067.800 1,070.907EUR -1,179,069 825.76 Loss of -269,908 on sale
2025-11-26BUY161,111.9901,098.100 1,099.489EUR 17,592 822.96
2025-11-26BUY161,111.9901,098.100 1,099.489EUR 17,592 822.96
2025-11-25SELL-2881,111.1101,073.250 1,077.036EUR -310,186 821.51 Loss of -73,592 on sale
2025-11-24SELL-561,075.7201,049.380 1,052.014EUR -58,913 820.25 Loss of -12,979 on sale
2025-11-20BUY1201,057.0001,038.250 1,040.125EUR 124,815 817.88
2025-11-19SELL-9121,055.5501,026.250 1,029.180EUR -938,612 816.68 Loss of -193,799 on sale
2025-11-18SELL-901,040.7241,017.255 1,019.602EUR -91,764 815.58 Loss of -18,362 on sale
2025-11-05BUY297955.410908.230 912.948EUR 271,146 807.48
2025-11-04BUY162915.220883.640 886.798EUR 143,661 806.93
2025-11-03BUY441901.339862.680 866.546EUR 382,147 806.44
2025-10-30BUY27853.000812.250 816.325EUR 22,041 805.92
2025-10-23BUY99821.040824.700 824.334EUR 81,609 805.48
2025-10-22BUY27812.430815.940 815.589EUR 22,021 805.44
2025-10-21BUY135799.570812.990 811.648EUR 109,572 805.47
2025-10-20BUY90808.960809.410 809.365EUR 72,843 805.45
2025-10-14BUY207812.350822.090 821.116EUR 169,971 805.22
2025-10-01BUY288825.420833.300 832.512EUR 239,763 805.01
2025-08-04SELL-80769.000774.480 773.932EUR -61,915 806.58 Profit of 2,612 on sale
2025-07-29SELL-80762.950779.490 777.836EUR -62,227 807.86 Profit of 2,402 on sale
2025-07-25BUY504812.690815.190 814.940EUR 410,730 807.83
2025-07-24BUY112805.430810.140 809.669EUR 90,683 807.85
2025-07-23BUY96798.890800.090 799.970EUR 76,797 807.91
2025-07-21BUY80762.180772.000 771.018EUR 61,681 808.42
2025-07-18BUY24771.710775.960 775.535EUR 18,613 808.66
2025-07-17BUY24761.500790.000 787.150EUR 18,892 808.98
2025-07-09BUY88786.920794.000 793.292EUR 69,810 809.72
2025-07-07BUY40772.870781.150 780.322EUR 31,213 810.20
2025-07-03BUY96780.670783.550 783.262EUR 75,193 810.62
2025-07-02SELL-204779.280779.840 779.784EUR -159,076 810.85 Profit of 6,337 on sale
2025-07-01BUY3,840775.900790.000 788.590EUR 3,028,186 811.10
2025-06-18SELL-112785.030790.630 790.070EUR -88,488 812.85 Profit of 2,552 on sale
2025-06-16BUY176807.580825.000 823.258EUR 144,893 813.06
2025-06-13SELL-20819.360825.000 824.436EUR -16,489 813.01 Loss of -228 on sale
2025-06-09BUY288773.710779.290 778.732EUR 224,275 813.43
2025-06-05SELL-24765.680770.000 769.568EUR -18,470 814.18 Profit of 1,071 on sale
2025-05-28BUY96719.390729.990 728.930EUR 69,977 818.02
2025-05-12BUY16755.570765.330 764.354EUR 12,230 826.76
2025-05-07BUY40776.720784.340 783.578EUR 31,343 828.92
2025-05-01BUY48794.100850.930 845.247EUR 40,572 829.96
2025-04-29BUY612885.200892.470 891.743EUR 545,747 828.65
2025-04-16BUY208734.900756.300 754.160EUR 156,865 828.03
2025-04-15BUY832757.180765.310 764.497EUR 636,062 828.87
2025-04-14BUY136754.350759.560 759.039EUR 103,229 829.75
2025-04-11BUY240732.410735.840 735.497EUR 176,519 830.93
2025-04-10BUY280720.910741.950 739.846EUR 207,157 832.27
2025-04-08BUY152726.240763.500 759.774EUR 115,486 834.57
2025-04-07BUY344723.730748.000 745.573EUR 256,477 835.98
2025-04-02BUY64818.220819.850 819.687EUR 52,460 837.48
2025-04-01BUY616805.230820.660 819.117EUR 504,576 837.90
2025-03-31BUY80825.910828.010 827.800EUR 66,224 838.06
2025-03-28BUY840822.510829.780 829.053EUR 696,405 838.27
2025-03-26BUY1,120826.760851.410 848.945EUR 950,818 838.66
2025-03-25BUY120852.350874.920 872.663EUR 104,720 838.47
2025-03-21BUY96837.570850.430 849.144EUR 81,518 838.10
2025-03-14BUY24813.480815.210 815.037EUR 19,561 838.88
2025-03-11BUY8824.060832.350 831.521EUR 6,652 840.02
2025-03-05BUY16929.720930.490 930.413EUR 14,887 838.14
2025-02-21BUY8873.680894.400 892.328EUR 7,139 827.47
2025-02-11SELL-168865.000874.190 873.271EUR -146,710 821.44 Loss of -8,707 on sale
2024-11-22BUY210748.010761.280 759.953EUR 159,590 835.99
2024-11-19BUY10729.730730.000 729.973EUR 7,300 854.32
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy